Safety of doTBal ® in Patients With Tuberculosis: Conduction of an Intensive Pharmacovigilance Program

Condition:   Tuberculosis Intervention:   Drug: Rifampicin/ Isoniazid/ Pyrazinamide/ Ethambutol Sponsor:   Laboratorios Silanes S.A. de C.V. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Research | Tuberculosis